CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
- 50 DMA₹78.65
- 100 DMA₹74.54
- 200 DMA₹65.32
Investment Returns
- Over 1 Month + 1.13%
- Over 3 Month -1.77%
- Over 6 Month + 56.6%
- Over 1 Year + 166.16%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹84.00
+
3.54
(4.4%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹78.81
- 50 Day
- ₹78.65
- 100 Day
- ₹74.54
- 200 Day
- ₹65.32
Resistance and Support
82.17
- R3 91.99
- R2 88.24
- R1 85.92
- S1 79.85
- S2 76.10
- S3 73.78
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹84 As on 12 February, 2026 | 07:09
The Market Cap of Concord Drugs is ₹110.7 Cr As on 12 February, 2026 | 07:09
The P/E ratio of Concord Drugs is 192.3 As on 12 February, 2026 | 07:09
The PB ratio of Concord Drugs is 2.9 As on 12 February, 2026 | 07:09
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.